We Help Companies Find New Sales Opportunities
Nycomed Amersham has sold its Nycomed Amersham Medical Systems subsidiary to a management buy-out team for £10m.
Nycomed Amersham is creating 27 new research jobs at its Cardiff laboratories, to work on a number of new drug development projects.
Nycomed Amersham is selling a 70% stake in its Norwegian-based pharmaceutical business to Nordic Capital in a deal that values the operation at £340m, in order to focus on imaging and biotech supply.
Nycomed Amersham is selling its chemical and pharmaceutical manufacturing operations in Puerto Rico to Searle for £40m.